Pure Bioscience, Inc (PURE)
Pure Bioscience, Inc. is a common stock listing on OTC Markets. The company develops and commercializes antimicrobial products designed to address pathogen control and hygiene needs in the United States and abroad. Its technology platform is built around silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent intended to provide residual protection and to be combined with other compounds. PURE Bioscience’s product lineup includes SDC-based disinfecting and sanitizing solutions such as PURE Hard Surface, PURE Control, PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, PURE Multi-Purpose Floor Cleaner, and SILVERION, which is used as a raw material ingredient in personal care products. The company serves customers in food processing, food service, hospitality, healthcare, facility care, transportation, and personal care, and distributes its products through end users and third-party distributors. Incorporated in 1992, the company is based in El Cajon, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-PURE
|
$0.051
|
-15.6% Downside
|
Fair
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
October 30, 2026
|
-3.8x
|
-1.4x
|
3.5x
|
8.438 M
|
13.926 M
|
43.5%
|
64.5%
|
-130.0
|
—
|
80.7%
|